- Home
- CMMB vs OCEA Comparison
CMMB vs OCEA Comparison
Compare CMMB & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- OCEA
- Stock Information
- Founded
- CMMB 2004
- OCEA 2019
- Country
- CMMB Israel
- OCEA United States
- Employees
- CMMB N/A
- OCEA N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- CMMB Health Care
- OCEA Health Care
- Exchange
- CMMB Nasdaq
- OCEA Nasdaq
- Market Cap
- CMMB 27.0M
- OCEA 30.4M
- IPO Year
- CMMB N/A
- OCEA N/A
- Fundamental
- Price
- CMMB $1.64
- OCEA $0.73
- Analyst Decision
- CMMB Strong Buy
- OCEA
- Analyst Count
- CMMB 3
- OCEA 0
- Target Price
- CMMB $5.67
- OCEA N/A
- AVG Volume (30 Days)
- CMMB 99.6K
- OCEA 65.5K
- Earning Date
- CMMB 11-14-2024
- OCEA 11-26-2024
- Dividend Yield
- CMMB N/A
- OCEA N/A
- EPS Growth
- CMMB N/A
- OCEA N/A
- EPS
- CMMB N/A
- OCEA N/A
- Revenue
- CMMB N/A
- OCEA N/A
- Revenue This Year
- CMMB N/A
- OCEA N/A
- Revenue Next Year
- CMMB N/A
- OCEA N/A
- P/E Ratio
- CMMB N/A
- OCEA N/A
- Revenue Growth
- CMMB N/A
- OCEA N/A
- 52 Week Low
- CMMB $0.42
- OCEA $0.52
- 52 Week High
- CMMB $2.55
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- CMMB 60.64
- OCEA 27.14
- Support Level
- CMMB $1.44
- OCEA $0.83
- Resistance Level
- CMMB $1.90
- OCEA $1.00
- Average True Range (ATR)
- CMMB 0.13
- OCEA 0.05
- MACD
- CMMB 0.04
- OCEA -0.02
- Stochastic Oscillator
- CMMB 67.49
- OCEA 6.38
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.